-
Recent Posts
- Compulsory Licensing in India: A historic move to make drugs affordable
- Open letter to DG, WHO – Pentavalent vaccine related deaths in India
- Global Week of Action: India- EU Free Trade Agreement (FTA)
- A victory for Novartis could spell death for millions
- Medicine prices shouldn’t rise: Supreme Court on Medicine Prices – AIDAN PIL, Nov 17, 2011
Tags
AIDAN Annual Meet Book release Clinical Trials Conflict of Interest draft policy Drug Pricing Drug Promotion Essential Drugs essential medicines Generic drug Global Health Health India India-EU FTA Letter Marketing Medical Council of India Medicine Medicine pricing Medicines National Pharmaceuticals Pricing Policy Patent Pharma Industry Pharma Policy Photo PIL Polio Price Control Rational Drugs Sec 3 (d) Supreme Court of India TRIPS Vaccine WHO-
Blog Stats
- 27,732 hits